Skip to main content
Home
Knowledge Base
for the National TB Elimination Program - NTEP
x

Main navigation

  • Home +
    • About Us
  • Curriculum +
    • Content view
    • List View
  • Knowledge Map +
    • Knowledge Map Summary
  • Documents
  • Page Library +
    • Content Page Summary
x

IEC-CH9: TB Comorbidity

  1. Home ›
  2. ›
  3. IEC-CH9: TB Comorbidity
Fullscreen
  • Comorbidity & special situation with TB

    Content

    Several medical conditions are risk factors for TB and poor TB treatment outcomes. Similarly, TB can complicate the course of some diseases. Therefore, it is important to identify these comorbidities in people diagnosed with TB to ensure early diagnosis and improved outcomes. When these conditions are highly prevalent in the general population, they can significantly contribute to the TB burden. Consequently, reducing the prevalence of these conditions can help prevent TB.

    TB shares underlying social determinants with many of these conditions. Addressing the social determinants of health is a shared responsibility across disease programmes and other stakeholders within and beyond the health sector. 

    Figure: Various comorbid and special situation related with tuberculosis

     

  • HIV in TB Patients

    Content

    The primary impact of HIV on TB is that the risk of developing TB becomes higher in patients with HIV. Overall, HIV-infected persons have an approximately 8-times greater risk of TB than persons without HIV infection. 

    Screen TB PLHIV patients for symptoms of TB and HIV

    Figure: Screening steps for TB - HIV patients

    Treatment for TB HIV Patients​

    • All TB patients who have been diagnosed and registered under NTEP should be referred for screening for HIV.
    • Referral of TB patients for screening for HIV and its recording & reporting is the responsibility of the Peripheral Health Institutions(PHI) where TB treatment is initiated.
    • TB patients diagnosed with HIV will receive the same duration of TB treatment with daily regimen as non-HIV TB patients.
    • TB patients must be referred to the nearest ART(Anti - Retroviral Treatment) centre for management of HIV.
  • Diabetes in TB Patients

    Content

    As a consequence of urbanization as well as social and economic development, there has been a rapidly growing epidemic of Diabetes Mellitus(DM). India has the second largest number of diabetic people in the world.

    Screen TB patients for symptoms of diabetes

     

    Figure: Screening steps for TB - Diabetic Patients

     

    Treatment for TB Diabetes Patients​

    • All TB patients who have been diagnosed and registered under NTEP will be referred for screening for Diabetes.
    • Referral of TB patients for screening for DM and its recording & reporting is the responsibility of the Peripheral Health Institutions(PHI) where TB treatment is initiated.
    • TB patients diagnosed with diabetes will receive the same duration of TB treatment with daily regimen as non-diabetic TB patients.
    • TB patients must be referred to the nearest healthcare facility for management of DM.
    • Regular monitoring of blood sugar levels is advised.
  • Malnutrition in TB Patients

    Content

    Malnutrition refers to deficiencies, excesses or imbalances in a person’s intake of energy and/or nutrients. The term malnutrition covers 2 broad groups of conditions.

    • One is ‘undernutrition’—which includes stunting(low height for age), wasting(low weight for height), underweight(low weight for age) and micronutrient deficiencies or insufficiencies(a lack of important vitamins and minerals).
    • The other is overweight, obesity and diet-related non communicable diseases (such as heart disease, stroke, diabetes, and cancer).

    Screen TB Malnutrition patients for nutritional needs

     

    Figure: Screening Steps for TB - Malnutrition patients

     

    Treatment for TB Malnutrition Patients

    Cases of TB with SAM and moderate undernutrition should be referred to the nearest health facility of NTEP for further management. Special focus should be given to the following categories:

    • Children below five years
    • School-age children and adolescents(Up to age 18 years)
    • Adults, including pregnant and lactating women, with active TB and SAM

     

  • Alcoholism in TB Patients

    Content

    About 10% TB deaths globally have been attributed to alcohol as a risk factor(WHO, Global TB Report 2017). Alcohol abuse is associated with threefold increase in risk of contracting tuberculosis.

    Side effects of anti TB drugs in this situation might get aggravated.

     

    Figure: Impact of Alcoholism on TB patients

     

    Treatment for Alcoholic TB Patients:

    • Patients with TB and a history of alcohol use should be referred to the nearest health facility of NTEP to manage TB and alcoholism.
    • While registering as a TB case, the status of alcohol use should be recorded in the patient records. If the TB patient is an alcohol user, he/she should be counselled to quit it. If the patient doesn't quit alcohol, s/he may be referred to the nearest alcohol de-addiction facility.
    • The patient should be assessed at every follow-up visit for TB and the status of use of alcohol.
    • At the end of treatment, his/her status of alcohol use should be recorded on the treatment card. If the patient has not quit alcohol, he/she should be referred to the nearest alcohol de-addiction facility and Alcohol Anonymous wherever available.
  • Tobacco in TB Patients

    Content

    Almost 38% of TB deaths are associated with the use of tobacco. The prevalence of TB is three times higher among ever-smokers as compared to that of never-smokers. Mortality from TB is three to four times higher among ever-smokers as compared to never-smokers. Smoking contributes to 50% of male deaths in the 25-69 age group from TB in India.

    Figure: Impact of Tobacco on TB patients

     

    Treatment for TB - Tobacco Patients:

    • While registering as a TB case, the status of tobacco use is recorded on the TB treatment card.
    • If the TB patient is a smoker or tobacco user, he/she is counselled to quit tobacco use. The patient is assessed at every visit for follow up for TB and the status of tobacco use.
    • At the end of treatment, his/her status of tobacco use is recorded in the treatment card. If the patient has not quit tobacco use, he/she will be referred to the nearest Tobacco Cessation Clinic(TCC) or Quit Line or M-Cessation Initiative.
  • Pregnancy and Lactation in TB Patients

    Content

    The presence of tuberculosis disease during pregnancy, delivery, and postpartum is known to result in unfavourable outcomes for both pregnant women and their infants. These outcomes include a roughly two-fold increased risk of preterm birth, low birth weight, intrauterine growth restriction, and a six-fold increase in perinatal death.

    Screen TB patients in Pregnancy & Lactating Patients

    Figure: Screening Steps in special situation - Pregnancy and Lactating TB Patients

     

    Treatment for TB - Pregnant & Lactating Patients

    • Cases of pregnant/lactating women with active TB should be referred to the nearest health facility of NTEP for further management.
    • They should be continued on iron and folic acid and other vitamins and minerals to complement their maternal micronutrient needs.
    • In situations when calcium intake is low, calcium supplementation is recommended as part of antenatal care.

     

  • COVID-19 in TB patients

    Content

    Tuberculosis and COVID-19 are infectious diseases which primarily attack the lungs. They present with similar symptoms of cough, fever and difficulty in breathing, although TB disease has a longer incubation period and a slower onset of disease.

     

    Screen patients for symptoms of TB and COVID-19

    Figure: Screening steps for TB - COVID 19 Patients

     

    Management of TB & COVID-19 Patients

    People with TB are likely to be at increased risk of COVID-19 infection, illness and death. So, TB patients should take precautions as advised by health authorities to be protected from COVID-19 and continue their TB treatment as prescribed.

     

    Prevention: While both TB and COVID-19 are spread by close contact between people, the exact mode of transmission differs. Thus, the patient should be explained the following measures to control disease spread.

    • Apart from that keeping rooms well ventilated, avoiding crowds and Respiratory precautions are thus important in the control of COVID-19 and TB Disease
© 2026 Knowledge Base, All rights reserved.

User account menu

  • Log in
⇡